🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to compare a new Magnetic Resonance Imaging (MRI)p...
Status
Completed
Location
Necker hospital
Start Date
2017-02-13
Trial ID
NCT02714933
Treatments Being Tested
The general goal of the present proposal, Progetto MOSAICO, is the identifi...
Status
Completed
Location
IRCCS E. Medea
Start Date
2018-01-02
Trial ID
NCT04769011
Purpose: The purpose of this study is to evaluate the Delay Alternating wit...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-12
Trial ID
NCT05505071
Treatments Being Tested
Glioblastoma multiforme (GBM) is the most common primary brain tumor, and i...
Status
Not Yet Recruiting
Location
CHU Amiens
Start Date
2025-12
Trial ID
NCT07211841
Treatments Being Tested
Since January 2010, a new magnetic resonance imaging scanner (Philips 3T, A...
Status
Completed
Location
Inserm U825
Start Date
2012-06-08
Trial ID
NCT05090956
Treatments Being Tested
Using MRI, many technical parameters can be changed to optimize the diagnos...
Status
Unknown
Location
Radiology Department CHU de Rennes
Start Date
2013-04
Trial ID
NCT03440983
Treatments Being Tested
The investigators propose a simple and non-invasive method to monitor heart...
Status
Completed
Location
Hospices Civils de Lyon
Start Date
2015-02-18
Trial ID
NCT02261870
Treatments Being Tested
The purpose of this study is to understand how different areas of the cereb...
Status
Not Yet Recruiting
Location
Hôpitaux Universitaires de Strasbourg
Start Date
2026-09-01
Trial ID
NCT07561229
Background: \- Researchers are interested in studying individuals who have...
Status
Recruiting
Location
Hope Center
Start Date
2010-07-21
Trial ID
NCT01143454
Treatments Being Tested
Prostate cancer is the second most common type of cancer in men only after ...
Status
Not Yet Recruiting
Location
CHU de Clermont-Ferrand
Start Date
2024-10
Trial ID
NCT06669273
Treatments Being Tested